Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

B Bienvenu1, K H Ly2, M Lambert3

  • 1Service de médecine interne, CHU de Caen, Normandie university, 14003 Caen, France.

La Revue De Medecine Interne
|February 3, 2016
PubMed

Insights

French experts established 31 consensus recommendations for managing giant cell arteritis (GCA), also known as Horton's disease. These guidelines aim to standardize GCA care, addressing diagnosis, treatment, and relapse management.

Area of Science:

  • Rheumatology
  • Vasculitis Research

Background:

  • Giant cell arteritis (GCA), or Horton's disease, presents management challenges due to existing uncertainties.
  • Standardized approaches are needed to optimize patient outcomes in GCA.

Purpose of the Study:

  • To develop comprehensive French national recommendations for the management of GCA.
  • To address uncertainties and harmonize GCA treatment standards across France.

Main Methods:

  • A multidisciplinary panel of 33 physicians from the French Study Group for Large Vessel Vasculitis (GEFA) developed the recommendations.
  • An iterative consensus-seeking process, literature review, and a 5-point Likert scale evaluation were employed.
  • Recommendations required ≥ 80% agreement among panel members for approval.

Main Results:

  • 31 consensus recommendations were established, covering 15 key topics in GCA management.
  • Recommendations address GCA nomenclature, classification, diagnostic tools (biopsy, imaging), and management of aorta involvement.
  • Guidance is provided on glucocorticoid regimens, complicated GCA treatment, use of immunosuppressants and biologics, and relapse management.

Conclusions:

  • The developed recommendations provide a standardized framework for GCA management in France.
  • These guidelines are intended to reduce uncertainties and harmonize clinical practice for GCA patients.
  • Regular updates are planned to ensure the recommendations remain current with evolving GCA research.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...